InvestorsHub Logo
Followers 5
Posts 339
Boards Moderated 3
Alias Born 03/27/2017

Re: None

Wednesday, 07/19/2017 12:39:40 PM

Wednesday, July 19, 2017 12:39:40 PM

Post# of 140
Verastem entering acceleration phase $VSTM

Biotech is an obvious area of high risk and we rarely get involved unless via limited risk option plays. Only on very low dollar value stocks do we consider outright purchases and we assume that the price can go to zero when assessing our risk. We also do a little research regarding what Phase they are in. Our favored position is to target stocks have have completed Phase 2 testing. Phase 1 often causes a short explosive trend that is short lived. A failure at Phase 2 will have catastrophic consequences for the share price. A successful Phase 2 increases the odds that they may be onto something and this trend can be both strong and of greater length. $VSTM is currently in that sweet spot of a Phase 3 trial.

Get Full Institutional Techncial Analysis for $VSTM with Charts HERE >>>>

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.